Filgrastim loading in PLGA and SLN nanoparticulate system: a bioinformatics approach

Drug Dev Ind Pharm. 2020 Aug;46(8):1354-1361. doi: 10.1080/03639045.2020.1788071. Epub 2020 Jul 9.

Abstract

Objective: In this research work, we hypothesized to predict the nanoparticulate system, best suited for targeted delivery of filgrastim. Significance: Targeted delivery of filgrastim to bone marrow is required to decrease the incidence of neutropenia/febrile neutropenia. This is achieved by nanoparticulate systems, duly designed by bioinformatics approach.

Method: The targeted delivery of filgrastim in nanoparticulate system was achieved by molecular dynamics (MD) simulation studies. Two matrices comprising PLGA and SLN (tripalmitin, core component of SLN system) were modeled separately with proposed drug filgrastim. Energy minimization of all systems was done using the steepest descent method. PLGA and tripalmitin systems were equalized at 310 °C, at 1 bar pressure with Berendsen barostat for 200 ps using a v-rescale thermostat for 100 ps. Atomistic MD simulations of four model system and mass density of interacting systems were calculated.

Results: The mass density maps of each nanoparticle system, that is, PLGA and tripalmitin showed an increase in density toward the end of the simulation. The contact numbers attained equilibria with the average number of approx.. 1500 contacts in case of tripalmitin-filgrastim system. While PLGA-filgrastim system shows lesser contacts as compared to tripalmitin with average contacts of approx. 1000.The binding free energy was predicted to be -1104 kJ/mol in tripalmitin-filgrastim complex and -421 kJ/mol in PLGA-filgrastim system.

Conclusion: Findings of study revealed that both nanoparticle systems assumed to be good model for drug-carrier systems. Though SLN systems were thought to be more appropriate than PLGA, still the in vivo findings could ascertain this hypothesis in futuristic work.

Keywords: Nanoparticles; PLGA; filgrastim; molecular dynamics simulation; protein–ligand interactions; tripalmitin.

MeSH terms

  • Computational Biology*
  • Drug Carriers
  • Filgrastim / chemistry*
  • Granulocyte Colony-Stimulating Factor / chemistry
  • Nanoparticles*
  • Recombinant Proteins / chemistry*

Substances

  • Drug Carriers
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim